Drug intelligence / Profile preview

UROVIA

Development stage: Unknown
Lead developer: Amvia Biotech
Administration: Oral

Overview

**UROVIA** is an oral Amvia Biotech product line supplied as capsules and syrup for renal stone support and urinary alkalization. Public product-catalog information describes it as a natural treatment for urinary disorders and renal stones, but does not identify its active constituents, standardized extract composition, or a specific molecular mechanism of action. ([amviabiotech.com](https://amviabiotech.com/wp-content/uploads/2025/05/Amvia_Biotech_Product_Catalogue_2025.pdf))

Brand names: UROVIA

Beyond the preview

Go deeper on UROVIA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UROVIA.

Explore the full profile